“…Several genes, such as HPGD, prostaglandinendoperoxidase synthase (PTGS) 1, PTGS2, prostaglandin E synthase (PTGES), PTGER1, prostaglandin E receptor (PTGER) 2, PTGER3, PTGER4, SLCO2A1, SLCO3A1, SLCO4A1, and PTGR2, are involved in the biosynthesis and signaling pathway of PGE2 [7]. A recent analysis suggested that patients with prostaglandin transporter SLCO2A1 mutations are more likely to develop myelofibrosis [8].…”